ICYMI: Risks associated with mortality in VEXAS
https://t.co/mpAc5shaMq https://t.co/FdOQcfwusp
TO THE NEW MONTHLY EMAIL
Reader Type Rheumatologist Patient or Concerned Individual Media/Press Other Healthcare Professional Other Physician Pharmaceutical Industry or Biotech Individual Pharmacist Physician Assistant, Nurse Practitioner, Rheumatology Nurse Primary Physician Trainee (Fellow, Resident, Student)
Monthly Topic Digests (Choose one or many) Autoinflammatory & Still's Disease (via StillsNow)
Email address: